ORGANIC
LETTERS
2003
Vol. 5, No. 26
5039-5042
Highly Enantioselective Hydrogenation
of Aromatic-Heteroaromatic Ketones
Cheng-yi Chen,* Robert A. Reamer, Jennifer R. Chilenski, and
Chris J. McWilliams
Department of Process Research, Merck & Co., Inc., P.O. Box 2000,
Rahway, New Jersey 07065-0900
Received October 24, 2003
ABSTRACT
Asymmetric hydrogenation of ketone 1 using trans-RuCl2[(R)-xylbinap][(R)-daipen] (3) as a catalyst afforded secondary alcohol 2 quantitatively
and in 99.4% ee. Further exploration of the effect of the thiazole ring substitution revealed that the catalyst was highly effective for the
enantioselective hydrogenation of 5-benzoyl thiazoles, which afforded corresponding alcohols in 92−99% ee. The same protocol was applicable
to a variety of aromatic-heteroaromatic ketones to generate secondary alcohols in excellent enantioselectivities.
Enantiomerically pure alcohols, especially those bearing
heterocycles, are important intermediates in the pharmaceuti-
cal industry and are usually available from the reduction of
ketones either by chemical means or biotransformation.1
Among the many protocols available for the transformation
of prochiral ketones to chiral alcohols, the catalytic, asym-
metric hydrogenation of ketones is one of the most efficient
and cost-effective methods.2 Chiral RuCl2(diphosphine)
(diamine) complexes pioneered by Noyori and co-workers,
catalyze rapid, highly efficient asymmetric hydrogenation of
a wide array of ketones in 2-propanol containing an alkaline
base to afford the corresponding alcohols.3 Recently, Burk
et al. has reported that the ruthenium complexes based upon
the novel PhanePhos ligands also serve as efficient catalyst
precursors for highly enantioselective hydrogenation of
ketones.4 Other ligands have also emerged that are useful
for the asymmetric hydrogenation of prochiral ketones.5
Although several methods for the asymmetric hydrogenation
of ketones exist, the enantioselective hydrogenation of
aromatic-heteroaromatic or bis heteroaromatic ketones re-
(2) (a) Noyori, R. AdV. Synth. Catal. 2003, 345, 15. (b) Wills, M.;
Hannedouche, J. Curr. Opin. Drug Dis. DeV. 2002, 5 (6), 881. (c) Chaplin,
D.; Harrison, P.; Henschke, J. P.; Lennon, I. C.; Meek, G.; Moran, P.;
Pilkington, C. J.; Ramsden, J. A.; Watkins, S.; Zanotti-Gerosa, A.. Org.
Process Res. DeV. 2003, 7 (1), 89. (d) Everaere, K.; Mortreux, A.;
Carpentier, J. AdV. Synth. Catal. 2003, 345, 67. (e) Blaser, H.; Malan, C.;
Pugin, B.; Spindler, F; Steiner, H.; Studer, M. AdV. Synth. Catal. 2003,
345, 103. (f) Noyori, R.; Okhuma, T. Angew. Chem., Int. Ed. 2001, 40, 40.
(3) (a) Doucet, H; Ohkuma, T.; Murata, K.; Yokozawa, M.; Katayama,
E.; England, a. F.; Ikariya, T.; Noyori, R. Angew. Chem., Int. Ed. 1998, 37,
1703. (b) Ohkuma, T.; Ooka, H.; Hashiguchi, S.; Ikariya, T.; Noyori, R. J.
Am. Chem. Soc. 1995, 117, 2675. (c) Ohkuma, T.; Koizumi, M.; Ikehira,
H.; Yokozawa, T.; Noyori, R. Org. Lett. 2000, 2, 659. (d) Ohkuma, T.;
Koizumi, M.; Yoshida, M.; H.; Noyori, R. Org. Lett. 2000, 2, 1749.
(4) Burk, M. J.; Hems, W.; Herzberg, D.; Malan, C.; Zanotti-Gerosa, A.
Org. Lett. 2000, 2 (26), 4173.
(1) (a) Roy, S.; Alexandre, V,; Neuwels, M,; Le Texier, L. AdV. Synth.
Catal. 2001, 343, 738. (b) Roszkowski, A. P.; Govier, W. M. Pharmacolo-
gist 1959, 1, 60. (c) Barouth, V.; Dall, H,; Petal, D.; Hite, G. J. Med. Chem.
1971, 14, 834. (d) Huang, W.; Pu, L. Tetrahedron Lett. 2000, 41 (2), 145.
(e) Salvi, N. A.; Chattopadhyay, S. Tetrahedron 2001, 57 (14), 2833. (f)
Masui, M.; Shioiri, T. Synlett. 1997, 3, 273. (g) Miyashita, A.; Matsuoka,
Y.; Suzuki, Y.; Iwamato, K.; Higashino, T. Chem. Pharm. Bull. 1997, 45,
1235. (h) Okano, K.; Murata, K.; Ikariya, T. Tetrahedron Lett. 2000, 41,
9277. (i) Takeshita, M.; Yoshida, S.; Sato, T.; Akutsu, N. Heterocycles
1993, 35, 879. (j) Vasse, J. L.; Charpentier, P.; Levacher, V.; Dupas, G.;
Queguiner, G.; Bourguignon, J. Synlett. 1998, 10, 1144. (k) Takemoto, M.;
Achiwa, K. Chem. Pharm. Bull. 1994, 42, 802. (l) Bolm, C.; Muniz, K.
Chem. Comm. 1999, 14, 1295. (m) Okano, K.; Murata, K.; Ikariya, T.
Tetrahedron Lett. 2000, 41, 9277.
(5) (a) Xie, J.-H.; Wang, L,-X.; Fu, Y.; zhu, S.-F.; Fan, B.-M.; Duan,
H.-F.; Zhou, Q.-L. J. Am. Chem. Soc. 2003, 125, 4404. (b) Wu, J.; Chen,
H.; Kwok, W.; Guo, R.; Zhou, Z.; Yeung, C.; Chan, A. S. C. J. Org. Chem.
2002, 67, 7908.
10.1021/ol0360795 CCC: $25.00 © 2003 American Chemical Society
Published on Web 11/27/2003